Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$1.98 +0.17 (+9.39%)
At close: Nov 12, 2026 · 4:00 PM EST

Harvard Apparatus Regenerative Technology (HRGN) Gains from Sales and Divestitures (2017 - 2018)

Updated

Harvard Apparatus Regenerative Technology's Gains from Sales and Divestitures came in at $1,000 for Q4 2018, compared with -$160,000 a year earlier.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Gains from Sales and Divestitures (2017 - 2018) Analysis & Trends

For FY2018, Harvard Apparatus Regenerative Technology's Gains from Sales and Divestitures was -$7,000.

  • Going back by year, Gains from Sales and Divestitures was -$160,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Harvard Apparatus Regenerative Technology 2.32 Mn -1.70 Mn 12,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1,000.00
Dec 31, 2017 -160,000.00
API Access

Harvard Apparatus Regenerative Technology Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=HRGN&period=max&api_key=YOUR_API_KEY